Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase II/III trial of PSA-IL2-GM-CSF-vaccine for the treatment of PSA recurrent prostate cancer in hormone-naive and hormone-independent patients

Next Previous
Search
Trial Profile

A phase II/III trial of PSA-IL2-GM-CSF-vaccine for the treatment of PSA recurrent prostate cancer in hormone-naive and hormone-independent patients

Status: Not yet recruiting
Phase of Trial: Phase II/III

Latest Information Update: 08 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PSA-IL2-GM-CSF vaccine (Primary)
  • Indications Prostate cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors OncBioMune Mexico; Theralink Technologies

    • Most Recent Events

    • 27 Jun 2017 According to an OncBioMune Pharmaceuticals media release, Mexico health authority, Comision Federal para la Proteccion contra Riesgos Sanitarios (COFEPRIS) has officially authorized commencement of this trial. The company is now working with the host hospital, principal investigators and others involved in the trial to begin enrollment immediately
    • 27 Jun 2017 Status changed from planning to not yet recruiting, as reported in an OncBioMune Pharmaceuticals media release.
    • 21 Jun 2017 According to an OncBioMune Pharmaceuticals media release, the company expect to announce the official commencement of this trial any day now.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top